Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].
Health Populi
JULY 11, 2019
This research organization will develop medicines targeting older adults — which makes sense because Clover Health’s target consumer market is Medicare Advantage beneficiaries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
NOVEMBER 5, 2018
With two months left in 2018, healthcare startups have already raised more in VC funding this year than they did in all of 2012 and 2013 combined, according to an analysis conducted for Forbes by Pitchbook. Reminder: In September 2018 each startup raised $20.7 In 2012 and 2013 combined, the sector raised $22.3 billion in 12 months.
Health Populi
JULY 26, 2022
Iora Health has focused on the Medicare-enrolled population, distinct from ONEM’s target patient market of younger, employed consumers. With PillPack, I wrote here in June 2018 that Amazon got 50 U.S. The deal was announced on 21 July, with Amazon striking the price at about $3.9 bn and MGM Studios for $8.5
Health Populi
MARCH 19, 2019
Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. To that point, IRI’s Kristin Hornberger presented new data on retail health market performance in 2018. Consumer health as a category was $45 billion in 2018, growing at 2.1%.
Health Populi
OCTOBER 28, 2019
The bar chart shows that PhRMA (the advocacy group for the pharmaceutical industry), Blue Cross & Blue Shield Association, the American Hospital Association, and the American Medical Association (representing physicians) were four of the ten highest spending lobbyers in 2018. A recent study on politics and health care spending in the U.S.
Health Populi
JANUARY 18, 2019
First, a Wall Street Journal profile of Bluebird Bio , a biotech firm that plans to sell gene-replacement therapy extending annual payments to patients based on whether the drug is effective. As the Harvard Chan-POLITICO study points out, prescription drug costs are top-of-mind for health consumers in America. and 300,000 people worldwide.
Expert insights. Personalized for you.
310 
Let's personalize your content